Company Filing History:
1 out of 1,218 
1 out of 134 
1 out of 214 
Years Active: 2000-2021
Title: Michelle A Ozbun: Innovator in Papillomavirus Research
Introduction
Michelle A Ozbun is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the field of papillomavirus research, holding a total of 3 patents. Her work focuses on developing innovative methods to combat human papillomavirus (HPV) infections and related cancers.
Latest Patents
One of her latest patents is titled "Arginine-rich polypeptide compositions and methods of using same." This invention includes an arginine-rich polypeptide composition that consists of an arginine-rich polypeptide and a pharmaceutically acceptable carrier. The polypeptide contains at least nine arginine residues, which represent at least 10% of the amino acid residues. This composition can be utilized in methods to inhibit HPV from binding to cells, as well as in treating subjects who have or are at risk of HPV infections. Another notable patent is "RhPV as a model for HPV-induced cancers," which provides an animal model system for studying papillomaviruses, particularly those causing anogenital and head and neck cancers. The Rhesus papillomavirus (RhPV1) serves as a valuable model for understanding human papillomaviruses that lead to anogenital infections and cancers.
Career Highlights
Throughout her career, Michelle has worked with esteemed organizations such as the Penn State Research Foundation and UNM Rainforest Innovations. Her research has significantly advanced the understanding of HPV and its implications in cancer development.
Collaborations
Michelle has collaborated with notable colleagues, including Craig M Meyers and Zurab Surviladze. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Michelle A Ozbun is a trailblazer in papillomavirus research, with a focus on developing effective treatments and models for understanding HPV-related diseases. Her contributions continue to impact the scientific community and pave the way for future innovations in this critical area of health.